REGENXBIO INC's ticker is RGNX and the CUSIP is 75901B107. A total of 156 filers reported holding REGENXBIO INC in Q3 2023. The put-call ratio across all filers is 0.47 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,583,309 | -32.5% | 217,698 | -18.0% | 0.00% | -25.0% |
| Q2 2023 | $5,306,286 | -26.3% | 265,447 | -30.3% | 0.00% | -33.3% |
| Q1 2023 | $7,200,001 | -17.3% | 380,751 | -0.8% | 0.01% | -14.3% |
| Q4 2022 | $8,707,578 | +4.7% | 383,932 | +22.0% | 0.01% | 0.0% |
| Q3 2022 | $8,318,000 | +40.5% | 314,718 | +31.3% | 0.01% | +40.0% |
| Q2 2022 | $5,920,000 | +271.6% | 239,665 | +399.3% | 0.01% | +400.0% |
| Q1 2022 | $1,593,000 | -62.9% | 47,997 | -54.2% | 0.00% | -75.0% |
| Q4 2019 | $4,290,000 | +93.5% | 104,713 | +68.1% | 0.00% | +100.0% |
| Q3 2019 | $2,217,000 | -26.4% | 62,275 | +6.2% | 0.00% | -33.3% |
| Q2 2019 | $3,013,000 | -41.7% | 58,649 | -34.9% | 0.00% | -40.0% |
| Q1 2019 | $5,166,000 | +153.1% | 90,140 | +85.3% | 0.01% | +150.0% |
| Q4 2018 | $2,041,000 | +69.8% | 48,657 | +205.6% | 0.00% | +100.0% |
| Q3 2018 | $1,202,000 | +8.1% | 15,923 | +2.7% | 0.00% | 0.0% |
| Q2 2018 | $1,112,000 | – | 15,504 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 847,424 | $13,948,599 | 12.64% |
| Sonic GP LLC | 518,079 | $8,527,580 | 8.28% |
| MPM BioImpact LLC | 656,718 | $10,809,578 | 2.89% |
| Redmile Group, LLC | 2,574,042 | $42,368,731 | 2.02% |
| ArchPoint Investors | 224,278 | $3,691,616 | 1.41% |
| WS MANAGEMENT LLLP | 618,131 | $10,174,436 | 0.82% |
| Redwood Wealth Management Group, LLC | 14,360 | $236,366 | 0.28% |
| HARBOR CAPITAL ADVISORS, INC. | 48,559 | $799,281 | 0.17% |
| PRENTISS SMITH & CO INC | 11,240 | $185,010 | 0.14% |
| LIBERTY ONE INVESTMENT MANAGEMENT, LLC | 36,522 | $601,152 | 0.09% |